Accessibility navigation

Choice of designs and doses for early phase trials

Zhou, Y. (2004) Choice of designs and doses for early phase trials. Fundamental & Clinical Pharmacology, 18 (3). pp. 373-378. ISSN 0767-3981

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1111/j.1472-8206.2004.00226.x


This paper reviews state-of-art statistical designs for dose-escalation procedures in first-into-man studies. The main focus will be on studies in oncology, as most statistical procedures for phase I trials have been proposed in this context. Extensions to situations such as the observation of bivariate outcomes and healthy volunteer studies are also discussed. The number of dose levels and cohort sizes used in early phase trials are considered. Finally, this paper raises some practical issues for dose-escalation procedures.

Item Type:Article
Divisions:Science > School of Mathematical, Physical and Computational Sciences > Department of Mathematics and Statistics > Applied Statistics
ID Code:9430
Uncontrolled Keywords:dose-escalation , first-into-man , statistical designs

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation